Perceptions of cancer of unknown primary site: a national survey of Australian medical oncologists

Despite being the sixth most common cause of cancer death in Australia, cancer of unknown primary (CUP) site remains poorly understood.

[1]  Kai Wang,et al.  Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Site: New Routes to Targeted Therapies. , 2015, JAMA oncology.

[2]  N. Pavlidis,et al.  Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  G. Varadhachary,et al.  Cancer of unknown primary site. , 2014, The New England journal of medicine.

[4]  J. Smith-Gagen,et al.  Cancer of unknown primary: time trends in incidence, United States , 2014, Cancer Causes & Control.

[5]  C. Vajdic,et al.  The challenge of attributing causality in cancer of unknown primary , 2013, International journal of cancer.

[6]  Ningyu Wang,et al.  18F-fluorodeoxyglucose positron emission tomography-computed tomography as a diagnostic tool in patients with cervical nodal metastases of unknown primary site: a meta-analysis. , 2013, Surgical oncology.

[7]  Y. Lawrence,et al.  Cancer of unknown primary: a population-based analysis of temporal change and socioeconomic disparities , 2013, British Journal of Cancer.

[8]  J. Hainsworth,et al.  Molecular gene expression profiling to predict the tissue of origin and direct site-specific therapy in patients with carcinoma of unknown primary site: a prospective trial of the Sarah Cannon research institute. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  A. Daud.  Removing the unknown from the carcinoma of unknown primary. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  L. Tanoue,et al.  The National Comprehensive Cancer Network , 1998, Cancer.

[11]  N. Laver,et al.  Cancer of unknown primary: from immunohistochemistry to gene expression profiling. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  Yasuhiro Fujiwara,et al.  Immunohistochemical Profile for Unknown Primary Adenocarcinoma , 2012, PloS one.

[13]  M. Mathieu,et al.  Identifying the Primary Site Using Gene Expression Profiling in Patients with Carcinoma of an Unknown Primary (CUP): A Feasibility Study from the GEFCAPI , 2012, Oncology Research and Treatment.

[14]  A. Loft,et al.  18F-FDG PET/CT as a diagnostic tool in patients with extracervical carcinoma of unknown primary site: a literature review. , 2011, The oncologist.

[15]  Jong Sun Park,et al.  Detection of primary sites in unknown primary tumors using FDG-PET or FDG-PET/CT , 2011, BMC Research Notes.

[16]  N. Zengi̇n,et al.  Whole body 18F-FDG PET/CT imaging in the detection of primary tumours in patients with a metastatic carcinoma of unknown origin. , 2008, Asian Pacific journal of cancer prevention : APJCP.

[17]  Kenneth R Hess,et al.  Molecular profiling of carcinoma of unknown primary and correlation with clinical evaluation. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  Arno Floore,et al.  Gene expression profiling to identify the histogenetic origin of metastatic adenocarcinomas of unknown primary. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  A. Floore,et al.  Gene expression profiling may improve diagnosis in patients with carcinoma of unknown primary , 2008, British Journal of Cancer.

[20]  O. Belohlávek,et al.  Prognostic and diagnostic accuracy of [18F]FDG-PET/CT in 190 patients with carcinoma of unknown primary , 2007, European Journal of Nuclear Medicine and Molecular Imaging.

[21]  T. Crosby,et al.  A clinical review of the investigation and management of carcinoma of unknown primary in a single cancer network. , 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).

[22]  K. Fizazi.  Treatment of patients with specific subsets of carcinoma of an unknown primary site. , 2006, Annals of Oncology.

[23]  Gerard J Fitzsimmons,et al.  From the Australian Institute of Health and Welfare , 2014, Communicable diseases intelligence quarterly report.

[24]  J. Roodenburg,et al.  Detection of unknown occult primary tumors using positron emission tomography , 1998, Cancer.

[25]  H. Furue.  [Unknown primary cancer]. , 1998, Gan to kagaku ryoho. Cancer & chemotherapy.

[26]  C. Muir.  Cancer of unknown primary site , 1995, Cancer.

[27]  D. Hedley,et al.  Metastatic adeno or undifferentiated carcinoma from an unknown primary site--natural history and guidelines for identification of treatable subsets. , 1987, The Quarterly journal of medicine.

[28]  J. Hainsworth,et al.  Advanced poorly differentiated carcinoma of unknown primary site: recognition of a treatable syndrome. , 1986, Annals of internal medicine.

[29]  E. Cadman,et al.  An analysis of 1539 patients with cancer of unknown primary site , 1986, Cancer.

[30]  M. Levine,et al.  Cost-effectiveness in the diagnosis and treatment of carcinoma of unknown primary origin. , 1985, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[31]  M. Tattersall,et al.  Unknown primary adenocarcinoma: incidence of overinvestigation and natural history. , 1979, British medical journal.